Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP & Chief Operating Officer | November 27, 2023 | November 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date November 27, 2023 · Filed November 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,338 |
Ending reported balance
After 2023-11-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-11-27 · Exercise / conversion · Acquired 406 · Balance 6,479 Row 2 · 2023-11-27 · Tax withholding · Disposed 141 · Balance 6,338 F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 813 |
Reported balance
After 2023-11-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-11-27 · Exercise / conversion · Disposed 406 · Balance 813 F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |
| Common StockSEC Table I · non-derivative | IndirectBerger Family Trust | 242 |
Reported balance
Holding disclosure · report date 2023-11-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 242 F2: The securities are held by the Berger Family Trust dated April 16, 2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2: The securities are held by the Berger Family Trust dated April 16, 2008.
F3: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F5: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2021 Filed Dec 2, 2021 00:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000216 · wf-form4_163840505486194.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000197 · wf-form4_163597229960218.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 110 | $136.39 | $15,002.90 |
DisclosureSEC source: 0001438133-21-000197 · wf-form4_163597229960218.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $136.32 to $136.53. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 890 | $135.61 | $120,692.90 |
DisclosureSEC source: 0001438133-21-000197 · wf-form4_163597229960218.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,357 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $135.05 to $136.00. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:45 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000197 · wf-form4_163597229960218.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:50 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 10,000 | $18.86 Strike: $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-21-000182 · wf-form4_163424460615495.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:50 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 10,000 | $129.28 | $1,292,823.00 |
DisclosureSEC source: 0001438133-21-000182 · wf-form4_163424460615495.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $129.25 to $129.49. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 20:50 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 10,000 | $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-21-000182 · wf-form4_163424460615495.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000180 · wf-form4_163338116397250.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,000 | $118.00 | $118,000.00 |
DisclosureSEC source: 0001438133-21-000180 · wf-form4_163338116397250.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-21-000180 · wf-form4_163338116397250.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 9,000 | $18.86 Strike: $18.86 | $169,740.00 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 4,300 | $122.64 | $527,333.08 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $122.20 to $122.77. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 3,068 | $121.66 | $373,262.39 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,547 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $121.19 to $122.16. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,632 | $120.93 | $197,359.23 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,615 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $120.19 to $121.17. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 21:18 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 9,000 | $18.86 | $169,740.00 |
DisclosureSEC source: 0001438133-21-000174 · wf-form4_163191347219012.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000141 · wf-form4_163044136697275.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,471 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Tandem common stock. F5 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 202 | $110.31 | $22,282.62 |
DisclosureSEC source: 0001438133-21-000141 · wf-form4_163044136697275.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000141 · wf-form4_163044136697275.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 5,000 | $18.86 Strike: $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-21-000137 · wf-form4_162931833451629.xml · derivative · entry 7 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 5,000 | $110.29 | $551,450.00 |
DisclosureSEC source: 0001438133-21-000137 · wf-form4_162931833451629.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.18 to $110.55. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 5,000 | $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-21-000137 · wf-form4_162931833451629.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 5,000 | $18.86 Strike: $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-21-000137 · wf-form4_162931833451629.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 5,000 | $109.40 | $547,000.00 |
DisclosureSEC source: 0001438133-21-000137 · wf-form4_162931833451629.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042 F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.18 to $109.67. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 5,000 | $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-21-000137 · wf-form4_162931833451629.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 1,854 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · derivative · entry 8 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,854 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,765 | $86.49 | $152,654.85 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042 Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,854 | $86.45 | $160,278.30 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,807 Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,854 | $9.00 | $16,686.00 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · derivative · entry 7 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,878 Underlying: Common Stock · 1,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F6 · kind: This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 681 | $85.65 | $58,327.65 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,807 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 23:27 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionWarrant · Derivative | 243 | $73.73 Strike: $73.73 | $17,915.42 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 7 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.expiration_date: The expiration dates for these warrants are August 31, 2021 (135 shares), July 3, 2022 (54 shares) and August 21, 2022 (54 shares). F3 · ownership.nature: The securities are held by the Berger Family Trust dated April 16, 2008. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 7,940 | $0.00 Strike: $81.63 | $0.00 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,940 Underlying: Common Stock · 7,940 shares Expires not disclosed F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F8 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantPerformance Stock Unit · Derivative | 2,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,599 Underlying: Common Stock · 2,599 shares Expires not disclosed F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F7 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F7 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F7 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 2,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,599 Underlying: Common Stock · 2,599 shares Expires not disclosed F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 201 | $89.14 | $17,917.14 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · Berger Family Trust Disclosed balance after: 242 F2 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. F3 · ownership.nature: The securities are held by the Berger Family Trust dated April 16, 2008. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 243 | $73.73 | $17,915.42 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · Berger Family Trust Disclosed balance after: 443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. F3 · ownership.nature: The securities are held by the Berger Family Trust dated April 16, 2008. Read SEC document |
| May 17, 2021 Filed May 21, 2021 01:37 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock | 296 | $66.76 | $19,760.96 |
DisclosureSEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,862 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 8,646 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000019 · wf-form4_161559971577102.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,854 Underlying: Common Stock · 8,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 8,646 | $90.22 | $780,043.85 |
DisclosureSEC source: 0001438133-21-000019 · wf-form4_161559971577102.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,566 F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $90.18 to $90.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| March 11, 2021 Filed Mar 13, 2021 01:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 8,646 | $9.00 | $77,814.00 |
DisclosureSEC source: 0001438133-21-000019 · wf-form4_161559971577102.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $18.86 | $0.00 |
DisclosureSEC source: 0001438133-20-000146 · wf-form4_160279341115393.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to fifty percent (50%) of the underlying shares on 06/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 5,000 | $119.25 | $596,250.00 |
DisclosureSEC source: 0001438133-20-000146 · wf-form4_160279341115393.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,566 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2020. Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 20:23 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 5,000 | $18.86 | $94,300.00 |
DisclosureSEC source: 0001438133-20-000146 · wf-form4_160279341115393.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:40 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001438133-20-000105 · wf-form4_159415440115391.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Stock Option · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares vested in twelve (12) equal monthly installments thereafter. F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:40 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 680 | $102.56 | $69,742.02 |
DisclosureSEC source: 0001438133-20-000105 · wf-form4_159415440115391.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,566 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. F4 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $102.01 to $102.73. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:40 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 680 | $2.59 | $1,761.20 |
DisclosureSEC source: 0001438133-20-000105 · wf-form4_159415440115391.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:40 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,320 | $101.19 | $133,567.90 |
DisclosureSEC source: 0001438133-20-000105 · wf-form4_159415440115391.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,566 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019. F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $100.94 to $101.51. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| July 06, 2020 Filed Jul 7, 2020 20:40 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,320 | $2.59 | $3,418.80 |
DisclosureSEC source: 0001438133-20-000105 · wf-form4_159415440115391.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.